Skip to main content
Erschienen in: Critical Care 6/2005

01.12.2005 | Commentary

Open the intensive care unit doors to HIV-infected patients with sepsis

verfasst von: Jean-François Timsit

Erschienen in: Critical Care | Ausgabe 6/2005

Einloggen, um Zugang zu erhalten

Abstract

Severe sepsis is more and more frequent, especially because of an increased rate of immunocompromised patients. Despite the improvement in the overall prognosis of HIV/AIDS patients and the improvement of global ICU care, the prognosis of HIV/ADS patients hospitalized in ICU with severe sepsis remained poor. This situation is partly due to the increased proportion of HIV/AIDS patients with limited access to health care and to a reluctance of ICU physicians in admitting HIV infected patients. However, medical literature suggests that ICU prognosis of immunocompromised (especially cancer) patients should be largely improved by early ICU admission and by an early institution of supportive techniques. This strategy should be used in HIV/AIDS patients with severe sepsis.
Literatur
1.
Zurück zum Zitat Annane D, Aegerter P, Jars-Guincestre MC, Guidet B: Current epidemiology of septic shock: the CUB-Rea Network. Am J Respir Crit Care Med 2003, 168: 165-172. 10.1164/rccm.2201087CrossRefPubMed Annane D, Aegerter P, Jars-Guincestre MC, Guidet B: Current epidemiology of septic shock: the CUB-Rea Network. Am J Respir Crit Care Med 2003, 168: 165-172. 10.1164/rccm.2201087CrossRefPubMed
2.
Zurück zum Zitat Martin GS, Mannino DM, Eaton S, Moss M: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003, 348: 1546-1554. 10.1056/NEJMoa022139CrossRefPubMed Martin GS, Mannino DM, Eaton S, Moss M: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003, 348: 1546-1554. 10.1056/NEJMoa022139CrossRefPubMed
3.
Zurück zum Zitat Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998, 338: 853-860. 10.1056/NEJM199803263381301CrossRefPubMed Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998, 338: 853-860. 10.1056/NEJM199803263381301CrossRefPubMed
4.
Zurück zum Zitat Spira R, Marimoutou C, Binquet C, Lacoste D, Dabis F: Rapid change in the use of antiretroviral agents and improvement in a population of HIV-infected patients: France, 1995–1997. Groupe d'Epidemiologie Clinique du SIDA en Aquitaine (GECSA). J Acquir Immune Defic Syndr Hum Retrovirol 1998, 18: 358-364.CrossRefPubMed Spira R, Marimoutou C, Binquet C, Lacoste D, Dabis F: Rapid change in the use of antiretroviral agents and improvement in a population of HIV-infected patients: France, 1995–1997. Groupe d'Epidemiologie Clinique du SIDA en Aquitaine (GECSA). J Acquir Immune Defic Syndr Hum Retrovirol 1998, 18: 358-364.CrossRefPubMed
5.
Zurück zum Zitat Pinget R, Cazein F, Lot F, Pillonel J, David D, Semaille C: Surveillance du SIDA en France – situation au 30 septembre 2002. Surveillance du VIH/sida en France 2003, 7-18. [http://www.invs.sante.fr] Pinget R, Cazein F, Lot F, Pillonel J, David D, Semaille C: Surveillance du SIDA en France – situation au 30 septembre 2002. Surveillance du VIH/sida en France 2003, 7-18. [http://​www.​invs.​sante.​fr]
6.
Zurück zum Zitat Morris A, Creasman J, Turner J, Luce JM, Wachter RM, Huang L: Intensive care of human immunodeficiency virus-infected patients during the era of highly active antiretroviral therapy. Am J Respir Crit Care Med 2002, 166: 262-267. 10.1164/rccm.2111025CrossRefPubMed Morris A, Creasman J, Turner J, Luce JM, Wachter RM, Huang L: Intensive care of human immunodeficiency virus-infected patients during the era of highly active antiretroviral therapy. Am J Respir Crit Care Med 2002, 166: 262-267. 10.1164/rccm.2111025CrossRefPubMed
7.
Zurück zum Zitat Vincent B, Timsit JF, Auburtin M, Schortgen F, Bouadma L, Wolff M, Regnier B: Characteristics and outcomes of HIV-infected patients in the ICU: impact of the highly active antiretroviral treatment era. Intensive Care Med 2004, 30: 859-866. 10.1007/s00134-004-2158-zCrossRefPubMed Vincent B, Timsit JF, Auburtin M, Schortgen F, Bouadma L, Wolff M, Regnier B: Characteristics and outcomes of HIV-infected patients in the ICU: impact of the highly active antiretroviral treatment era. Intensive Care Med 2004, 30: 859-866. 10.1007/s00134-004-2158-zCrossRefPubMed
8.
Zurück zum Zitat Narasimhan M, Posner AJ, DePalo VA, Mayo PH, Rosen MJ: Intensive care in patients with HIV infection in the era of highly active antiretroviral therapy. Chest 2004, 125: 1800-1804. 10.1378/chest.125.5.1800CrossRefPubMed Narasimhan M, Posner AJ, DePalo VA, Mayo PH, Rosen MJ: Intensive care in patients with HIV infection in the era of highly active antiretroviral therapy. Chest 2004, 125: 1800-1804. 10.1378/chest.125.5.1800CrossRefPubMed
9.
Zurück zum Zitat Casalino E, Mendoza-Sassi G, Wolff M, Bedos JP, Gaudebout C, Regnier B, Vachon F: Predictors of short- and long-term survival in HIV-infected patients admitted to the ICU. Chest 1998, 113: 421-429.CrossRefPubMed Casalino E, Mendoza-Sassi G, Wolff M, Bedos JP, Gaudebout C, Regnier B, Vachon F: Predictors of short- and long-term survival in HIV-infected patients admitted to the ICU. Chest 1998, 113: 421-429.CrossRefPubMed
10.
Zurück zum Zitat Casalino E, Wolff M, Ravaud P, Choquet C, Bruneel F, Regnier B: Impact of HAART advent on admission patterns and survival in HIV-infected patients admitted to an intensive care unit. AIDS 2004, 18: 1429-1433. 10.1097/01.aids.0000131301.55204.a7CrossRefPubMed Casalino E, Wolff M, Ravaud P, Choquet C, Bruneel F, Regnier B: Impact of HAART advent on admission patterns and survival in HIV-infected patients admitted to an intensive care unit. AIDS 2004, 18: 1429-1433. 10.1097/01.aids.0000131301.55204.a7CrossRefPubMed
11.
Zurück zum Zitat Nuesch R, Geigy N, Schaedler E, Battegay M: Effect of highly active antiretroviral therapy on hospitalization characteristics of HIV-infected patients. Eur J Clin Microbiol Infect Dis 2002, 21: 684-687. 10.1007/s10096-002-0792-3CrossRefPubMed Nuesch R, Geigy N, Schaedler E, Battegay M: Effect of highly active antiretroviral therapy on hospitalization characteristics of HIV-infected patients. Eur J Clin Microbiol Infect Dis 2002, 21: 684-687. 10.1007/s10096-002-0792-3CrossRefPubMed
12.
Zurück zum Zitat Morris A, Huang L: Intensive care of patients with HIV infection: HAART warming improvement but beware of future HAART (and heart) attacks. Chest 2004, 125: 1602-1604. 10.1378/chest.125.5.1602CrossRefPubMed Morris A, Huang L: Intensive care of patients with HIV infection: HAART warming improvement but beware of future HAART (and heart) attacks. Chest 2004, 125: 1602-1604. 10.1378/chest.125.5.1602CrossRefPubMed
13.
Zurück zum Zitat Mrus JM, Braun LA, Yi MS, Linde-Zwirble WT, Johnston JA: Impact of HIV/AIDS on care and outcomes of severe sepsis. Critical Care 2005, 9: R623-R630. 10.1186/cc3811PubMedCentralCrossRefPubMed Mrus JM, Braun LA, Yi MS, Linde-Zwirble WT, Johnston JA: Impact of HIV/AIDS on care and outcomes of severe sepsis. Critical Care 2005, 9: R623-R630. 10.1186/cc3811PubMedCentralCrossRefPubMed
14.
Zurück zum Zitat Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29: 1303-1310. 10.1097/00003246-200107000-00002CrossRefPubMed Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29: 1303-1310. 10.1097/00003246-200107000-00002CrossRefPubMed
15.
Zurück zum Zitat Garrouste-Orgeas M, Montuclard L, Timsit JF, Reignier J, Desmettre T, Karoubi P, Moreau D, Montesino L, Duguet A, Boussat S, et al.: Predictors of intensive care unit refusal in French intensive care units: a multiple-center study. Crit Care Med 2005, 33: 750-755. 10.1097/01.CCM.0000157752.26180.F1CrossRefPubMed Garrouste-Orgeas M, Montuclard L, Timsit JF, Reignier J, Desmettre T, Karoubi P, Moreau D, Montesino L, Duguet A, Boussat S, et al.: Predictors of intensive care unit refusal in French intensive care units: a multiple-center study. Crit Care Med 2005, 33: 750-755. 10.1097/01.CCM.0000157752.26180.F1CrossRefPubMed
16.
Zurück zum Zitat Le Gall JR, Lemeshow S, Saulnier F: A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. J Am Med Assoc 1993, 270: 2957-2963. 10.1001/jama.270.24.2957CrossRef Le Gall JR, Lemeshow S, Saulnier F: A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. J Am Med Assoc 1993, 270: 2957-2963. 10.1001/jama.270.24.2957CrossRef
17.
Zurück zum Zitat Larche J, Azoulay E, Fieux F, Mesnard L, Moreau D, Thiery G, Darmon M, Le Gall JR, Schlemmer B: Improved survival of critically ill cancer patients with septic shock. Intensive Care Med 2003, 29: 1688-1695. 10.1007/s00134-003-1957-yCrossRefPubMed Larche J, Azoulay E, Fieux F, Mesnard L, Moreau D, Thiery G, Darmon M, Le Gall JR, Schlemmer B: Improved survival of critically ill cancer patients with septic shock. Intensive Care Med 2003, 29: 1688-1695. 10.1007/s00134-003-1957-yCrossRefPubMed
Metadaten
Titel
Open the intensive care unit doors to HIV-infected patients with sepsis
verfasst von
Jean-François Timsit
Publikationsdatum
01.12.2005
Verlag
BioMed Central
Erschienen in
Critical Care / Ausgabe 6/2005
Elektronische ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc3923

Weitere Artikel der Ausgabe 6/2005

Critical Care 6/2005 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.